Topic

mRNA

The latest mRNA news and analysis from Tech Arcade.

Moderna and Merck's Cancer Vaccine Cleared Phase 3. The Stock Doubled Before Anyone Saw the Numbers.

Moderna and Merck's personalized mRNA cancer vaccine cleared Phase 3 in 1,137 melanoma patients — and Moderna's stock more than doubled before the full numbers were even released.

Aug 25, 2026 · 4 min

Biotech

Moderna's mRNA Flu Shot Beat the Standard Jab by 27% — and the FDA Nearly Never Reviewed It

The FDA just approved mFlusiva, the first mRNA flu vaccine ever — 26.6% more effective than the standard shot in adults 50+, six months after the agency refused to review it.

Aug 7, 2026 · 4 min